EDX Medical Group plc (AQSE:EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and...
test
A new editorial was published in Oncotarget's Volume 15 on December 24, 2024, titled "Pitfalls and perils from FDA-approved germ-line cancer predisposition tests."...
News ReleaseThursday, June 6, 2024 Initiative aims to improve health outcomes by integrating research in everyday primary care settings. The...
Descrease article font size Increase article font size B.C. residents will soon become the first in Canada to have access...
